论文部分内容阅读
目的:对治疗急性胰腺炎的3种用药方案进行成本-效果比较,寻找最佳治疗方案。方法:查阅相关治疗急性胰腺炎的资料,按不同的给药方案将其分为3组,运用药物经济学中的成本-效果法进行分析。结果:3种给药方案的临床疗效无显著差异(P>0.05),但成本间却存在显著差异,联合组7 063.14元、前列腺素E_1组18 505.48元、生长抑素组6 235.7元。结论:3组方案中生长抑素组为最佳方案。
OBJECTIVE: To compare the cost-effectiveness of the three drug regimens for the treatment of acute pancreatitis and find the best treatment plan. Methods: The related data of acute pancreatitis were consulted and divided into 3 groups according to different dosing regimens. The cost-effectiveness method was used to analyze the data. Results: There was no significant difference in the clinical efficacy between the three dosing regimens (P> 0.05), but there were significant differences among the costs. The combined group was 7 063.14 yuan, the prostaglandin E 1 group was 18 505.48 yuan, and the somatostatin group was 6 235.7 yuan. Conclusion: The three groups of programs somatostatin group for the best program.